VOL. XCIV, NO. 247

★ WIDE MOAT STOCKS COMPARISON ★

NO ADVICE

Wednesday, January 7, 2026

Stock Comparison

Bureau Veritas S.A. vs Cochlear Limited

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

Bureau Veritas S.A.

BVI · Euronext Paris

Market cap (USD)$12B
Gross margin (TTM)22.7%
Operating margin (TTM)14%
Net margin (TTM)9.3%
SectorIndustrials
IndustryConsulting Services
CountryFR
Data as of2025-12-28
Moat score
66/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Bureau Veritas S.A.'s moat claims, evidence, and risks.

View BVI analysis

Cochlear Limited

COH · ASX

Market cap (USD)$17B
Gross margin (TTM)74.5%
Operating margin (TTM)22.7%
Net margin (TTM)16.2%
SectorHealthcare
IndustryMedical - Devices
CountryAU
Data as of2026-01-04
Moat score
81/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Cochlear Limited's moat claims, evidence, and risks.

View COH analysis

Comparison highlights

  • Moat score gap: Cochlear Limited leads (81 / 100 vs 66 / 100 for Bureau Veritas S.A.).
  • Segment focus: Bureau Veritas S.A. has 6 segments (29.3% in Buildings & Infrastructure); Cochlear Limited has 3 segments (62.4% in Cochlear Implants).
  • Primary market structure: Competitive vs Oligopoly. Pricing power: Moderate vs Moderate.
  • Moat breadth: Bureau Veritas S.A. has 6 moat types across 3 domains; Cochlear Limited has 8 across 3.

Primary market context

Bureau Veritas S.A.

Buildings & Infrastructure

Market

Construction, buildings and infrastructure inspection/testing and project assurance

Geography

Global

Customer

Developers, contractors, infrastructure operators, public authorities

Role

Third-party testing/inspection and compliance verification across project lifecycle

Revenue share

29.3%

Cochlear Limited

Cochlear Implants

Market

Cochlear implant systems (internal implant + external sound processors) for severe-to-profound hearing loss

Geography

Global

Customer

Hospitals/ENT clinics and audiology programs (providers) serving implant candidates/recipients; reimbursed by public/private payers

Role

Medical device OEM / platform owner (implant + processor + fitting software + clinical support)

Revenue share

62.4%

Side-by-side metrics

Bureau Veritas S.A.
Cochlear Limited
Ticker / Exchange
BVI - Euronext Paris
COH - ASX
Market cap (USD)
$12B
$17B
Gross margin (TTM)
22.7%
74.5%
Operating margin (TTM)
14%
22.7%
Net margin (TTM)
9.3%
16.2%
Sector
Industrials
Healthcare
Industry
Consulting Services
Medical - Devices
HQ country
FR
AU
Primary segment
Buildings & Infrastructure
Cochlear Implants
Market structure
Competitive
Oligopoly
Market share
n/a
60%-65% (reported)
HHI estimate
n/a
n/a
Pricing power
Moderate
Moderate
Moat score
66 / 100
81 / 100
Moat domains
Legal, Supply, Demand
Demand, Legal, Supply
Last update
2025-12-28
2026-01-04

Moat coverage

Shared moat types

Service Field NetworkCapex Knowhow Scale

Bureau Veritas S.A. strengths

Regulated Standards PipeProcurement InertiaOperational ExcellenceSwitching Costs General

Cochlear Limited strengths

Brand TrustCompliance AdvantageIP Choke PointInstalled Base ConsumablesFormat Lock InData Workflow Lockin

Segment mix

Bureau Veritas S.A. segments

Full profile >

Marine & Offshore

Oligopoly

8.1%

Agri-Food & Commodities

Competitive

20.3%

Industry

Competitive

21.1%

Buildings & Infrastructure

Competitive

29.3%

Certification

Competitive

8.4%

Consumer Products Services

Competitive

12.8%

Cochlear Limited segments

Full profile >

Cochlear Implants

Oligopoly

62.4%

Services

Monopoly

25.9%

Acoustics

Oligopoly

11.7%

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Looking for expansion-stage stocks?

Proven models entering the expansion stage with unit economics that work.

View expansion-stage stocks

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.